Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.

Mai KT, Landry DC, Robertson SJ, Commons AS, Burns BF, Thijssen A, Collins J.

Pathol Res Pract. 2001;197(10):671-5.

PMID:
11700888
2.

Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.

Mai KT, Alhalouly T, Lamba M, Yazdi HM, Stinson WA.

Diagn Cytopathol. 2003 Feb;28(2):66-70.

PMID:
12561022
3.

Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features.

Mai KT, Kohler DM, Roustan Delatour NL, Veinot JP.

Pathol Res Pract. 2006;202(12):863-8. Epub 2006 Oct 10.

PMID:
17034957
4.

Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.

Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG.

Cancer. 2008 Apr 1;112(7):1480-8. doi: 10.1002/cncr.23322.

5.
6.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

7.

Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.

Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS.

BJU Int. 2012 Dec;110(11 Pt B):E673-8. doi: 10.1111/j.1464-410X.2012.11498.x. Epub 2012 Sep 14.

8.

Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study.

Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, Wegener G, Thüroff JW, Hofmann R, Stöckle M, Siemer S, Schrader M, Hartmann A, Kuczyk MA, Junker K, Schrader AJ.

Eur J Cancer. 2012 Oct;48(15):2347-52. doi: 10.1016/j.ejca.2012.05.002. Epub 2012 Jun 13.

PMID:
22698386
9.

Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters.

Tsai WC, Sheu LF, Nieh S, Yu CP, Sun GH, Lin YF, Chen A, Jin JS.

World J Urol. 2007 Mar;25(1):73-80. Epub 2006 Sep 23.

PMID:
17021824
10.

Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.

de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB.

Am J Surg Pathol. 2001 Mar;25(3):275-84.

PMID:
11224597
11.

The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.

Kuczyk M, Wegener G, Jonas U.

Eur Urol. 2005 Aug;48(2):252-7. Epub 2005 Apr 21.

PMID:
15936136
12.

Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.

Ingimarsson JP, Hardarson S, Petursdottir V, Jonsson E, Einarsson GV, Gudbjartsson T.

Scand J Urol Nephrol. 2011 Nov;45(5):306-11. doi: 10.3109/00365599.2011.579576. Epub 2011 May 27.

PMID:
21619417
13.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
14.

Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.

Strojan Fležar M, Gutnik H, Jeruc J, Kirbiš IS.

Virchows Arch. 2011 Dec;459(6):607-14. doi: 10.1007/s00428-011-1156-0. Epub 2011 Nov 4.

PMID:
22052200
15.

Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.

Onishi T, Oishi Y, Goto H, Tomita M, Abe K, Sugaya S.

Int J Urol. 2001 Jun;8(6):268-74.

16.

Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.

Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM.

Radiographics. 2009 May-Jun;29(3):741-54; discussion 755-7. doi: 10.1148/rg.293085190. Review.

PMID:
19448113
17.

Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.

Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M.

BJU Int. 2008 Nov;102(10):1381-4. doi: 10.1111/j.1464-410X.2008.07999.x. Epub 2008 Sep 8.

19.

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP.

Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.

PMID:
23871402
20.

Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.

Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B; Swedish Kidney Cancer Quality Register Group.

Eur Urol. 2011 Nov;60(5):975-82. doi: 10.1016/j.eururo.2011.06.029. Epub 2011 Jul 1.

PMID:
21741160
Items per page

Supplemental Content

Write to the Help Desk